Live from the NIH registry
Studies recruiting near Poughkeepsie right now
Top 25 of 77 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
NonSegmental Vitiligo
Phase 3
Interventional 180 participants sought
Vitality Clinical Research Llc — Woodbury, New York (24.8 mi)
· Sponsor: Incyte Corporation
Molecular Genetics Studies of Cancer Patients and Their Relatives
Malignant Neoplasm
N/A
Observational 999,999 participants sought
Health Quest Medical Practice PC-Cardio Thoracic — Poughkeepsie, New York (0.4 mi)
· Sponsor: City of Hope Medical Center
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Alzheimer Disease
Phase 3
Interventional 426 participants sought
Mid Hudson Medical Research — New Windsor, New York (16.0 mi)
· Sponsor: Bristol-Myers Squibb
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 2, Phase 3
Interventional 1,092 participants sought
Westchester Putnam Gastroenterology — Carmel, New York (22.1 mi)
· Sponsor: Janssen Research & Development, LLC
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
Asthma
N/A
Interventional 400 participants sought
Sun River Health — Beacon, New York (13.4 mi)
· Sponsor: Columbia University
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Heart Failure and Impaired Kidney Function
Phase 3
Interventional 4,800 participants sought
Research Site — New Windsor, New York (16.0 mi)
· Sponsor: AstraZeneca
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Chronic Obstructive Pulmonary Disease
Phase 3
Interventional 942 participants sought
Mid Hudson Medical Research - New Windsor- Site Number : 8400004 — New Windsor, New York (16.0 mi)
· Sponsor: Sanofi
Product Surveillance Registry
Cardiac Rhythm Disorders, Urological Disorders
N/A
Observational 100,000 participants sought
Research site — Poughkeepsie, New York (0.4 mi)
· Sponsor: Medtronic
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Depressive Disorder, Major
Phase 3
Interventional 752 participants sought
Lucian Miron Manu MD Psychiatry PC — Woodbury, New York (24.8 mi)
· Sponsor: Janssen Research & Development, LLC
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Metastatic Cancer, Neoplasm, Prostate
Phase 2
Interventional 192 participants sought
VA Hudson Valley Health Care System — Wappingers Falls, New York (6.8 mi)
· Sponsor: Sun Pharmaceutical Industries Limited
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
Irritable Bowel Syndrome
Phase 2
Interventional 420 participants sought
GSK Investigational Site — New Windsor, New York (16.0 mi)
· Sponsor: GlaxoSmithKline
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Alzheimer Disease, Agitation
Phase 3
Interventional 650 participants sought
Local Institution - 1656 — New Windsor, New York (16.0 mi)
· Sponsor: Bristol-Myers Squibb
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 3
Interventional 530 participants sought
Westchester Putnam Gastroenterology — Carmel, New York (22.1 mi)
· Sponsor: Janssen Research & Development, LLC
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Prostate Cancer
Phase 2
Interventional 900 participants sought
Hudson Valley Urology, PC — Poughkeepsie, New York (0.4 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Cardiovascular Disease
Phase 3
Interventional 15,100 participants sought
Research Site — Poughkeepsie, New York (0.4 mi)
· Sponsor: AstraZeneca
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
Melanoma, Glioma
Phase 1
Interventional 124 participants sought
Optum Medical Care, PC — Brewster, New York (25.9 mi)
· Sponsor: Pfizer
Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
Hypertriglyceridemia
Phase 2
Interventional 316 participants sought
Marea Site 318 — New Windsor, New York (16.0 mi)
· Sponsor: Marea Therapeutics
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
Nuvance Health — Poughkeepsie, New York (0.4 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Early Alzheimer's Disease
Phase 2
Interventional 340 participants sought
Mid Hudson Medical Research ( Site 1050) — New Windsor, New York (16.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting
Ulcerative Colitis, Crohn's Disease
Phase 4
Interventional 400 participants sought
Westchester Putnam Gastroenterology PC — Carmel, New York (22.1 mi)
· Sponsor: Takeda
International Weight Control Registry
Weight Loss, Overweight
N/A
Observational 100,000 participants sought
United States Military Academy, West Point — West Point, New York (21.0 mi)
· Sponsor: Tufts University
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Alopecia Areata
Phase 3
Interventional 355 participants sought
Vitality Clinical Trials — Woodbury, New York (24.8 mi)
· Sponsor: Sun Pharmaceutical Industries, Inc.
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Vassar Brothers Medical Center — Poughkeepsie, New York (0.4 mi)
· Sponsor: NRG Oncology
Collection of Samples USOPTIVAL Study
Colorectal Cancer (CRC), Advanced Adenomas (AA)
N/A
Observational 1,300 participants sought
Mid Hudson Medical Research — New Windsor, New York (16.0 mi)
· Sponsor: Universal Diagnostics
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 960 participants sought
GSK Investigational Site — New Windsor, New York (16.0 mi)
· Sponsor: GlaxoSmithKline